ConductScience.org, home

Gene · 10133

Papers4,137

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

241 to 260 of 4,137

Download this page as JSON
TitleJournalYearPMIDFound bySource
OPTN/SRTR 2022 Annual Data Report: Lung.Am J Transplant202438431363PubTator, text miningPubMed
OPTN/SRTR 2022 Annual Data Report: Intestine.Am J Transplant202438431361PubTator, text miningPubMed
OPTN/SRTR 2022 Annual Data Report: Kidney.Am J Transplant202438431360PubTator, text miningPubMed
OPTN/SRTR 2022 Annual Data Report: Liver.Am J Transplant202438431359PubTator, text miningPubMed
OPTN/SRTR 2022 Annual Data Report: Introduction.Am J Transplant202438431357PubTator, text miningPubMed
OPTN/SRTR 2022 Annual Data Report: Preface.Am J Transplant202438431356PubTator, text miningPubMed
[Optineurin and mitochondrial dysfunction in neurodegeneration].Med Sci (Paris)202438411425PubTator, text miningPubMed
Molecular genetics of inherited normal tension glaucoma.Indian J Ophthalmol202438389252PubTator, text miningPubMed
Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising target.Biomed Pharmacother202438364733PubTator, text miningPubMed
Roles and mechanisms of optineurin in bone metabolism.Biomed Pharmacother202438350370PubTator, text miningPubMed
Critical appraisal of the piRNA-PIWI axis in cancer and cancer stem cells.Biomark Res202438303021PubTator, text miningPubMed
Mitochondrial dysfunction: A promising therapeutic target for liver diseases.Genes Dis202438299199PubTator, text miningPubMed
Optineurin provides a mitophagy contact site for TBK1 activation.EMBO J202438287189PubTator, text miningPubMed
Primary Lateral Sclerosis: An Overview.J Clin Med202438276084PubTator, text miningPubMed
Liver transplant activity for alcohol-associated hepatitis after OPTN diagnosis updates.Liver Transpl202438270587PubTator, text miningPubMed
Glaucoma Animal Models beyond Chronic IOP Increase.Int J Mol Sci202438255979PubTator, text miningPubMed
Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson's Disease.Biomolecules202438254673PubTator, text miningPubMed
Lysosomal Dysfunction: Connecting the Dots in the Landscape of Human Diseases.Biology (Basel)202438248465PubTator, text miningPubMed
ATG14 targets lipid droplets and acts as an autophagic receptor for syntaxin18-regulated lipid droplet turnover.Nat Commun202438245527PubTator, text miningPubMed
Next-generation sequencing-based gene panel tests for the detection of rare variants and hypomorphic alleles associated with primary open-angle glaucoma.PLoS One202438241218PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/10133/papers?page=13